{
    "Trade/Device Name(s)": [
        "illumigene\u00ae Group B Streptococcus (GBS)",
        "illumigene\u00ae Group B Streptococcus (GBS) External Control Kit"
    ],
    "Submitter Information": "Meridian Bioscience, Inc.",
    "510(k) Number": "K112125",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062948"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "NJR"
    ],
    "Summary Letter Date": "November 17, 2011",
    "Summary Letter Received Date": "November 18, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3740"
    ],
    "Regulation Name(s)": [
        "Nucleic acid amplification assay system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Streptococcus agalactiae (Group B Streptococcus)"
    ],
    "Specimen Type(s)": [
        "Vaginal/Rectal swab (enriched in Lim Broth or TransVag Broth)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "illumipro-10\u2122 Automated Isothermal Amplification and Detection System"
    ],
    "Method(s)/Technology(ies)": [
        "Loop-mediated isothermal amplification (LAMP)",
        "DNA amplification"
    ],
    "Methodologies": [
        "Molecular amplification testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "External Control Kit"
    ],
    "Document Summary": "FDA 510(k) summary for illumigene Group B Streptococcus (GBS) DNA amplification assay for detection of GBS from enriched vaginal/rectal swab specimens using LAMP technology",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for detection of Group B Streptococcus in antepartum women from enriched vaginal/rectal swab specimens (Lim Broth or TransVag Broth) using molecular amplification technology; not intended for point-of-care use",
    "fda_folder": "Microbiology"
}